US pharma industry sees a drop of 22.2% in deal activity in July 2019
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the last 12-month average, according to GlobalData’s…

The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the last 12-month average, according to GlobalData’s…
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData’s deals database. Embed…
Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData’s…
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData’s deals database. Embed this…
Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData’s deals database.…
Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData’s deals database.…
Total pharma industry M&A deals in Q2 2019 worth $19.5bn were announced in the US, according to GlobalData’s deals…
Total pharma industry deals for June 2019 worth $102.8bn were announced globally, according to GlobalData’s deals database. Embed this…
The US pharma industry saw a drop of 30.5% in overall deal activity during June 2019, when compared with…
Thank you for subscribing to Pharmaceutical Technology